Development of a new experimental NMR strategy for covalent cysteine protease inhibitors screening: toward enhanced drug discovery.
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
22 Aug 2024
22 Aug 2024
Historique:
received:
08
07
2024
accepted:
13
08
2024
medline:
26
8
2024
pubmed:
26
8
2024
entrez:
26
8
2024
Statut:
epublish
Résumé
In the development of antiviral drugs, proteases and polymerases are among the most important targets. Cysteine proteases, also known as thiol proteases, catalyze the degradation of proteins by cleaving peptide bonds using the nucleophilic thiol group of cysteine. As part of our research, we are examining how cysteine, an essential amino acid found in the active site of the main protease (M
Identifiants
pubmed: 39184001
doi: 10.1039/d4ra04938a
pii: d4ra04938a
pmc: PMC11342919
doi:
Types de publication
Journal Article
Langues
eng
Pagination
26829-26836Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There are no conflicts to declare.